Year 1

In the first year of this program, we have initiated the planned clinical trial of stem cell gene therapy for sickle cell disease. A first subject with Sickle Cell Disease has been enrolled and a first bone marrow harvest performed to produce a first cell product. The planned autologous transplant will be performed within the next quarter. This approach has the potential to provide a novel therapeutic approach for sickle cell disease.